T1	Observation 63 67	aged
T2	Measurement 68 85	50 years or older
T3	Condition 90 109	Alzheimer's disease
T4	Observation 139 147	DSM-IV15
T5	Observation 149 163	NINCDS-ADRDA16
T6	Observation 178 193	standard MMSE-K
T7	Measurement 194 202	10 to 26
T8	Condition 237 245	Dementia
T9	Drug 461 466	AChEI
T10	Drug 469 476	Tacrine
T11	Drug 478 487	Donepezil
T12	Drug 489 501	Rivastigmine
T13	Condition 513 521	dementia
T14	Drug 606 610	drug
T15	Temporal_measurement 611 625	within 15 days
T16	Condition 669 695	Neurodegenerative diseases
T17	Condition 703 722	Parkinson's disease
T18	Condition 724 738	Pick's disease
T19	Condition 740 760	Huntington's disease
T20	Condition 762 775	Down syndrome
T21	Condition 782 790	Dementia
T22	Condition 802 813	head trauma
T23	Condition 818 826	dementia
T24	Condition 838 850	brain damage
T25	Condition 858 874	cerebral hypoxia
T26	Condition 877 897	hypoxic brain damage
T27	Procedure_Device 904 933	cardiopulmonary resuscitation
T28	Condition 935 955	hypoxic brain damage
T29	Procedure_Device 962 969	surgery
T30	Condition 971 991	hypoxic brain damage
T31	Condition 999 1008	addiction
T32	Condition 1010 1030	hypoxic brain damage
T33	Condition 1038 1043	shock
T34	Condition 1050 1061	brain tumor
T35	Condition 1063 1077	nerve syphilis
T36	Condition 1079 1089	meningitis
T37	Condition 1091 1103	encephalitis
T38	Condition 1105 1116	brain tumor
T39	Condition 1121 1128	amentia
T40	Condition 1133 1141	epilepsy
T41	Qualifier 1146 1151	major
T42	Condition 1152 1163	psychiatric
T44	Condition 1181 1197	major depression
T45	Condition 1202 1215	schizophrenia
T46	Condition 1220 1247	treatment-resistant gastric
T47	Condition 1252 1264	peptic ulcer
T48	Qualifier 1283 1301	clinically serious
T49	Condition 1302 1355	hepatic, renal, lung, endocrinal or metabolic disease
T50	Condition 1358 1365	thyroid
T51	Condition 1367 1378	parathyroid
T52	Condition 1380 1389	pituitary
T53	Condition 1391 1404	renal failure
T54	Condition 1406 1423	diabetes mellitus
T55	Procedure_Device 1517 1530	heart surgery
T56	Temporal_measurement 1531 1546	within 6 months
T57	Condition 1575 1596	myocardial infarction
T58	Qualifier 1612 1621	untreated
T59	Condition 1622 1646	congestive heart failure
T60	Qualifier 1662 1668	severe
T61	Condition 1669 1678	disorders
T62	Anatomic_location 1686 1698	mitral valve
T63	Anatomic_location 1702 1714	aortic valve
T64	Drug 1752 1773	investigational drugs
T65	Temporal_measurement 1774 1797	within the past 1 month
T66	Qualifier 1861 1873	uncontrolled
T67	Condition 1874 1891	diabetes mellitus
T68	Condition 2051 2067	hypersensitivity
T69	Condition 2071 2078	allergy
T70	Drug 2084 2108	cholinesterase inhibitor
T71	Observation 2336 2339	Age
T72	Measurement 2340 2357	55 years or above
T73	Qualifier 2431 2439	Probable
T74	Condition 2440 2442	AD
T75	Observation 2446 2461	NIA-AA criteria
T76	Drug 2485 2504	Cognitive enhancers
T77	Qualifier 2525 2536	stable dose
T79	Temporal_measurement 2541 2558	the last 3 months
T80	Qualifier 2744 2753	Corrected
T81	Observation 2754 2767	visual acuity
T82	Observation 2944 2947	Age
T83	Measurement 2948 2959	55 or above
T84	Qualifier 3068 3077	Corrected
T85	Observation 3078 3091	visual acuity
T86	Condition 2908 2915	healthy
T87	Condition 3232 3234	AD
T88	Observation 3255 3265	MOCA score
T89	Measurement 3266 3270	< 10
T90	Observation 3276 3287	DSM IV - TR
T91	Temporal_measurement 3303 3310	current
T92	Condition 3322 3335	mood disorder
T93	Temporal_measurement 3336 3356	in the last 3 months
T94	Observation 3362 3373	DSM IV - TR
T95	Observation 3440 3451	DSM IV - TR
T96	Observation 3524 3535	DSM IV - TR
T97	Temporal_measurement 3389 3396	current
T98	Condition 3397 3413	anxiety disorder
T99	Temporal_measurement 3467 3474	current
T100	Temporal_measurement 3551 3558	current
T101	Condition 3475 3497	substance use disorder
T102	Temporal_measurement 3414 3434	in the last 3 months
T103	Temporal_measurement 3498 3518	in the last 3 months
T104	Condition 3571 3597	primary psychotic disorder
T105	Temporal_measurement 3562 3570	lifetime
T106	Condition 3616 3639	intellectual disability
T107	Condition 3645 3672	neurodevelopmental disorder
T108	Procedure_Device 3678 3713	Electroconvulsive Therapy treatment
T110	Condition 3753 3760	seizure
T111	Negation_cue 3761 3771	other than
T112	Condition 3774 3789	febrile seizure
T113	Temporal_measurement 3793 3800	infancy
T114	Temporal_measurement 3806 3815	Currently
T115	Drug 3823 3838	Anticonvulsants
T116	Drug 3842 3857	Benzodiazepines
T117	Condition 3868 3884	contraindication
T118	Procedure_Device 3889 3892	TMS
T119	Qualifier 3900 3905	other
T120	Condition 3906 3937	medical condition/circumstances
T121	Condition 4033 4040	healthy
T122	Observation 4090 4101	DSM IV - TR
T123	Negation_cue 4112 4122	other than
T124	Condition 4123 4137	simple phobias
T125	Condition 4141 4160	Adjustment disorder
T126	Qualifier 4170 4175	other
T127	Condition 4176 4197	neurological disorder
T128	Anatomic_location 4208 4230	central nervous system
T129	Drug 4236 4259	Psychotropic medication
T130	Negation_cue 4260 4266	except
T131	Drug 4271 4279	sedative
T132	Drug 4281 4290	hypnotics
T133	Qualifier 4296 4307	stable dose
T135	Temporal_measurement 4312 4328	at least 4 weeks
T137	Condition 4345 4352	seizure
T138	Negation_cue 4353 4363	other than
T139	Condition 4366 4381	febrile seizure
T140	Temporal_measurement 4385 4392	infancy
T141	Temporal_measurement 4398 4407	Currently
T142	Drug 4415 4430	Anticonvulsants
T143	Drug 4434 4449	Benzodiazepines
T144	Condition 4459 4475	contraindication
T145	Procedure_Device 4480 4483	TMS
T146	Qualifier 4491 4496	other
T147	Condition 4497 4528	medical condition/circumstances
T148	Measurement 4659 4676	50 years or older
T149	Condition 4764 4782	Alzheimer's diseas
T150	Observation 4793 4946	National Institute of Neurological and Communicative Disorders and Stroke/Alzheimer's Disease and Related Disorders Association ( NINCDS/ADRDA ) criteria
T151	Observation 4951 4980	Mini-Mental Status Exam score
T152	Measurement 4981 4985	< 25
T153	Observation 4990 5029	Modified Hachinski Ischemia Scale score
T154	Measurement 5033 5037	<= 4
T155	Observation 5042 5077	Geriatric Depression Scales ( GDS )
T157	Measurement 5078 5083	<= 10
T159	Condition 5101 5128	non-child bearing potential
T160	Qualifier 5132 5140	negative
T161	Observation 5141 5170	urine or blood pregnancy test
T162	Condition 5275 5300	neurodegenerative disease
T163	Condition 5311 5330	Parkinson's disease
T164	Condition 5332 5358	diffuse Lewy body dementia
T166	Qualifier 5373 5384	significant
T167	Condition 5385 5408	cerebrovascular disease
T168	Qualifier 5431 5453	clinically significant
T169	Qualifier 5454 5462	abnormal
T170	Observation 5463 5479	laboratory value
T171	Qualifier 5487 5509	clinically significant
T172	Qualifier 5510 5518	unstable
T173	Condition 5519 5549	medical or psychiatric illness
T174	Condition 5574 5582	disorder
T175	Procedure_Device 5673 5697	gastrointestinal surgery
T176	Observation 5612 5635	absorption distribution
T177	Observation 5637 5647	metabolism
T178	Observation 5651 5660	excretion
T179	Qualifier 5732 5754	clinically significant
T180	Condition 5755 5913	gastrointestinal, cardiovascular, hepatic, renal, hematological, neoplastic, endocrine, neurological, immunodeficiency, pulmonary or other disorder or disease
T181	Observation 5969 5990	NINCDS/ADRDA criteria
T182	Qualifier 5995 6003	probable
T183	Condition 6004 6006	AD
T184	Observation 6011 6015	MMSE
T185	Measurement 6016 6031	between 12 - 27
T186	Drug 6053 6077	cholinesterase inhibitor
T187	Drug 6084 6123	NMDA ( N-methyl-D-asparate ) antagonist
T188	Qualifier 6129 6140	stable dose
T190	Temporal_measurement 6145 6162	at least 12 weeks
T191	Qualifier 6507 6519	Stable doses
T193	Condition 6523 6546	non-excluded medication
T194	Condition 6566 6587	hepatic insufficiency
T195	Negation_cue 6551 6553	No
T197	Condition 6722 6739	Diabetes Mellitus
T198	Observation 6742 6755	OGTT criteria
T199	Drug 6786 6818	excluded antidiabetic medication
T201	Condition 6847 6859	hypoglycemia
T202	Qualifier 6864 6870	Active
T203	Condition 6871 6895	hepatic or renal disease
T204	Condition 6900 6915	Cardiac disease
T206	Condition 6937 6961	congestive heart failure
T207	Temporal_measurement 6965 6972	current
T208	Drug 6973 6982	treatment
T209	Condition 6987 6990	CHF
T211	Temporal_measurement 7003 7009	recent
T212	Condition 7010 7031	myocardial infarction
T213	Drug 7051 7071	investigational drug
T214	Qualifier 7043 7050	another
T215	Temporal_measurement 7072 7098	within the past two months
T217	Qualifier 7114 7136	clinically significant
T218	Condition 7137 7143	stroke
T220	Condition 7159 7166	seizure
T221	Condition 7170 7215	head trauma with disturbance of consciousness
T222	Temporal_measurement 7216 7241	within the past two years
T223	Qualifier 7246 7251	Major
T224	Condition 7252 7266	mental illness
T225	Condition 7277 7296	psychotic disorders
T226	Condition 7298 7314	bipolar disorder
T227	Condition 7318 7342	major depressive episode
T228	Temporal_measurement 7343 7368	within the past two years
T229	Temporal_measurement 7394 7401	Current
T230	Temporal_measurement 7480 7487	Current
T231	Temporal_measurement 7549 7556	Current
T232	Drug 7409 7433	oral hypoglycemic agents
T233	Drug 7444 7457	sulfonylureas
T234	Drug 7462 7475	meglintinides
T235	Temporal_measurement 7491 7495	past
T236	Drug 7511 7518	insulin
T237	Measurement 7523 7544	longer than two weeks
T238	Drug 7564 7631	drugs with significant anticholinergic or antihistaminic properties
T239	Qualifier 7699 7707	probable
T240	Condition 7708 7734	Alzheimer's disease ( AD )
T242	Observation 7748 7891	National Institute of Neurological Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association ( NINCDS/ADRDA ) criteria
T243	Observation 7898 7942	Mini-Mental State Examination ( MMSE ) score
T244	Measurement 7946 7960	>= 3 and <= 12
T245	Temporal_measurement 8416 8423	current
T246	Condition 8424 8457	medical or neurological condition
T247	Negation_cue 8458 8468	other than
T248	Condition 8469 8471	AD
T249	Temporal_measurement 8520 8527	current
T250	Temporal_measurement 8586 8593	current
T251	Temporal_measurement 8655 8662	current
T252	Qualifier 8765 8787	Clinically significant
T253	Condition 8788 8807	urinary obstruction
T254	Condition 8676 8687	bradycardia
T255	Measurement 8689 8716	< 50 beats per minute [bpm]
T256	Condition 8719 8738	sick-sinus syndrome
T257	Condition 8742 8760	conduction defects
T259	Condition 8823 8833	malignancy
T260	Temporal_measurement 8854 8877	within the past 5 years
T261	Anatomic_location 8841 8853	organ system
T262	Temporal_measurement 8961 8968	Current
T263	Qualifier 8985 8991	active
T264	Condition 8992 9012	skin lesion/disorder
T265	Condition 9097 9156	exaggerated pharmacological sensitivity or hypersensitivity
T266	Drug 9177 9189	rivastigmine
T267	Drug 9160 9165	drugs
T268	Qualifier 9196 9201	other
T269	Drug 9202 9223	cholinergic compounds
T270	Drug 9317 9354	Succinylcholine-type muscle relaxants
T271	Temporal_measurement 9355 9382	during the previous 2 weeks
T272	Drug 9387 9394	Lithium
T273	Temporal_measurement 9395 9422	during the previous 2 weeks
T274	Drug 9430 9450	investigational drug
T275	Temporal_measurement 9451 9478	during the previous 4 weeks
T276	Drug 9485 9489	drug
T277	Condition 9518 9545	major organ system toxicity
T278	Temporal_measurement 9546 9573	during the previous 4 weeks
T279	Drug 9578 9590	Rivastigmine
T280	Drug 9622 9631	donepezil
T281	Drug 9633 9644	galantamine
T282	Qualifier 9646 9651	other
T283	Drug 9652 9677	cholinesterase inhibitors
T284	Drug 9684 9691	tacrine
T285	Drug 9693 9706	physostigmine
T286	Drug 9710 9724	pyridostigmine
T287	Condition 9760 9779	Alzheimer's disease
T288	Temporal_measurement 9780 9807	during the previous 2 weeks
T289	Qualifier 9827 9833	stable
T291	Drug 9849 9858	memantine
T290	Temporal_measurement 9863 9880	at least 3 months
T292	Qualifier 9730 9735	other
T293	Drug 9736 9755	approved treatments
T294	Drug 9933 9954	anticholinergic drugs
T295	Drug 9965 10006	tricyclic and tetracyclic antidepressants
T296	Temporal_measurement 10007 10034	during the previous 4 weeks
T297	Drug 10039 10049	Selegiline
T298	Qualifier 10068 10079	stable dose
T300	Temporal_measurement 10080 10107	during the previous 4 weeks
T301	Drug 10112 10139	Peripheral anticholinergics
T302	Qualifier 10155 10166	stable dose
T304	Temporal_measurement 10167 10194	during the previous 4 weeks
T305	Qualifier 11196 11212	medically stable
T306	Temporal_measurement 11232 11239	current
T307	Qualifier 11240 11244	dose
T308	Drug 11248 11266	rivastigmine patch
T309	Measurement 11831 11850	Older than 65 years
T310	Condition 11868 11876	dementia
T311	Observation 11887 11967	Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition ( DSM-IV )
T313	Condition 12337 12360	cardiopulmonary disease
T314	Qualifier 12365 12370	other
T315	Condition 12371 12397	exercise contraindications
T316	Qualifier 12402 12407	Other
T317	Condition 12408 12448	neuromuscular or musculoskeletal disease
T318	Temporal_measurement 12485 12491	Recent
T319	Condition 12492 12498	stroke
T320	Condition 12500 12508	fracture
T321	Procedure_Device 12512 12530	orthopedic surgery
R1	has_value Arg1:T1 Arg2:T2	
R2	has_value Arg1:T6 Arg2:T7	
R3	has_TempMea Arg1:T14 Arg2:T15	
R4	modified_by Arg1:T42 Arg2:T41	
R5	modified_by Arg1:T49 Arg2:T48	
R6	has_TempMea Arg1:T55 Arg2:T56	
R7	modified_by Arg1:T59 Arg2:T58	
R8	modified_by Arg1:T61 Arg2:T60	
R9	has_TempMea Arg1:T64 Arg2:T65	
R10	modified_by Arg1:T67 Arg2:T66	
R11	has_value Arg1:T71 Arg2:T72	
R12	modified_by Arg1:T74 Arg2:T73	
R13	modified_by Arg1:T76 Arg2:T77	
R14	has_TempMea Arg1:T76 Arg2:T79	
T43	Qualifier 2768 2774	enough
R15	modified_by Arg1:T81 Arg2:T80	
R16	modified_by Arg1:T81 Arg2:T43	
R17	has_value Arg1:T82 Arg2:T83	
R18	modified_by Arg1:T85 Arg2:T84	
R19	has_value Arg1:T88 Arg2:T89	
R20	has_TempMea Arg1:T92 Arg2:T91	
R21	has_TempMea Arg1:T92 Arg2:T93	
R22	has_TempMea Arg1:T98 Arg2:T97	
R23	has_TempMea Arg1:T98 Arg2:T102	
R24	has_TempMea Arg1:T101 Arg2:T99	
R25	has_TempMea Arg1:T101 Arg2:T103	
R26	has_TempMea Arg1:T104 Arg2:T105	
R27	has_TempMea Arg1:T104 Arg2:T100	
R28	has_TempMea Arg1:T110 Arg2:T113	
R29	has_TempMea Arg1:T115 Arg2:T114	
R30	has_TempMea Arg1:T116 Arg2:T114	
R31	modified_by Arg1:T120 Arg2:T119	
R32	modified_by Arg1:T127 Arg2:T126	
R33	modified_by Arg1:T129 Arg2:T133	
R34	has_TempMea Arg1:T129 Arg2:T135	
R35	has_TempMea Arg1:T137 Arg2:T140	
R36	has_TempMea Arg1:T142 Arg2:T141	
R37	has_TempMea Arg1:T143 Arg2:T141	
R38	modified_by Arg1:T147 Arg2:T146	
R39	has_value Arg1:T151 Arg2:T152	
R40	has_value Arg1:T153 Arg2:T154	
R41	modified_by Arg1:T161 Arg2:T160	
R42	has_value Arg1:T155 Arg2:T157	
R43	modified_by Arg1:T167 Arg2:T166	
R44	modified_by Arg1:T170 Arg2:T169	
R45	modified_by Arg1:T170 Arg2:T168	
R46	modified_by Arg1:T173 Arg2:T172	
R47	modified_by Arg1:T173 Arg2:T171	
R48	modified_by Arg1:T180 Arg2:T179	
R49	modified_by Arg1:T183 Arg2:T182	
R50	has_value Arg1:T184 Arg2:T185	
R51	modified_by Arg1:T187 Arg2:T188	
R52	modified_by Arg1:T186 Arg2:T188	
R53	has_TempMea Arg1:T187 Arg2:T190	
R54	has_TempMea Arg1:T186 Arg2:T190	
R55	modified_by Arg1:T193 Arg2:T191	
R56	modified_by Arg1:T203 Arg2:T202	
R57	has_TempMea Arg1:T208 Arg2:T207	
R58	has_TempMea Arg1:T212 Arg2:T211	
R59	modified_by Arg1:T213 Arg2:T214	
R60	has_TempMea Arg1:T213 Arg2:T215	
R61	modified_by Arg1:T218 Arg2:T217	
R62	has_TempMea Arg1:T221 Arg2:T222	
R63	has_TempMea Arg1:T220 Arg2:T222	
R64	modified_by Arg1:T224 Arg2:T223	
R65	has_TempMea Arg1:T224 Arg2:T228	
R66	has_TempMea Arg1:T232 Arg2:T229	
R67	has_TempMea Arg1:T236 Arg2:T235	
R68	has_TempMea Arg1:T236 Arg2:T230	
R69	has_value Arg1:T236 Arg2:T237	
R70	has_TempMea Arg1:T238 Arg2:T231	
R71	modified_by Arg1:T240 Arg2:T239	
R72	has_value Arg1:T243 Arg2:T244	
R73	has_TempMea Arg1:T246 Arg2:T245	
T78	Qualifier 8541 8561	probable or possible
T109	Condition 8562 8579	vascular dementia
R74	modified_by Arg1:T109 Arg2:T78	
R75	has_TempMea Arg1:T109 Arg2:T249	
T134	Qualifier 8607 8613	severe
T156	Condition 8626 8648	cardiovascular disease
R77	modified_by Arg1:T156 Arg2:T134	
T136	Qualifier 8617 8625	unstable
R76	modified_by Arg1:T156 Arg2:T136	
R78	has_TempMea Arg1:T156 Arg2:T250	
R79	modified_by Arg1:T253 Arg2:T252	
R80	has_TempMea Arg1:T259 Arg2:T260	
R81	modified_by Arg1:T264 Arg2:T263	
R82	has_TempMea Arg1:T264 Arg2:T262	
R83	modified_by Arg1:T269 Arg2:T268	
R84	has_TempMea Arg1:T270 Arg2:T271	
R85	has_TempMea Arg1:T272 Arg2:T273	
R86	has_TempMea Arg1:T274 Arg2:T275	
R87	has_TempMea Arg1:T276 Arg2:T278	
T158	Qualifier 9593 9597	oral
T165	Qualifier 9601 9618	transdermal patch
R88	modified_by Arg1:T279 Arg2:T158	
R89	modified_by Arg1:T279 Arg2:T165	
R90	modified_by Arg1:T283 Arg2:T282	
R91	modified_by Arg1:T293 Arg2:T292	
R92	modified_by Arg1:T291 Arg2:T289	
R93	has_TempMea Arg1:T291 Arg2:T290	
R94	has_TempMea Arg1:T279 Arg2:T288	
R95	has_TempMea Arg1:T280 Arg2:T288	
R96	has_TempMea Arg1:T281 Arg2:T288	
R97	has_TempMea Arg1:T283 Arg2:T288	
R98	has_TempMea Arg1:T293 Arg2:T288	
R99	modified_by Arg1:T301 Arg2:T302	
T189	Negation_cue 10140 10143	not
R100	has_TempMea Arg1:T301 Arg2:T304	
R101	modified_by Arg1:T297 Arg2:T298	
R102	has_TempMea Arg1:T297 Arg2:T300	
R103	modified_by Arg1:T308 Arg2:T307	
R104	has_TempMea Arg1:T308 Arg2:T306	
T192	Observation 11971 12081	The International Statistical Classification of Diseases and Related Health Problems 10th Revision ( ICD- 10 )
R105	modified_by Arg1:T315 Arg2:T314	
R106	modified_by Arg1:T317 Arg2:T316	
R107	has_TempMea Arg1:T319 Arg2:T318	
R108	has_TempMea Arg1:T320 Arg2:T318	
R109	has_TempMea Arg1:T321 Arg2:T318	
R110	is_negated Arg1:T112 Arg2:T111	
R111	is_negated Arg1:T124 Arg2:T123	
R112	is_negated Arg1:T125 Arg2:T123	
R113	is_negated Arg1:T131 Arg2:T130	
R114	is_negated Arg1:T132 Arg2:T130	
R115	is_negated Arg1:T139 Arg2:T138	
R116	is_negated Arg1:T194 Arg2:T195	
R117	is_negated Arg1:T248 Arg2:T247	
R118	is_negated Arg1:T302 Arg2:T189	
